Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002611 · ClinicalTrials.gov registry record · Phase 3
Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
A Phase 3 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,031
- Enrollment target
NCT00002611 is a Phase 3 study that has completed, run by Children's Oncology Group. The registered enrollment target is 3,031 participants.
The verdict
NCT00002611, a Phase 3 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,031 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high energy x-rays to damage tumor cells. It is not yet known whether combination chemotherapy alone or combination chemotherapy plus radiation therapy is more effective for childhood kidney cancer. PURPOSE: Phase III trial to compare the effectiveness of combination chemotherapy with or without radiation therapy in treating children who have kidney cancer.
Interventions
- DRUG cyclophosphamide
- DRUG etoposide
- BIOLOGICAL filgrastim
- DRUG doxorubicin hydrochloride
- BIOLOGICAL dactinomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,031 participants |
| Start Date | 1995-07 |
| Est. Completion | 2003-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002611
The ClinicalTrials.gov registry entry for NCT00002611 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 3,031 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cyclophosphamide is the first listed.
NCT00002611 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002611 about?
NCT00002611 is a clinical study titled "Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high energy x-rays to damage tumor cells. It is not yet known whether combination chemotherapy alone or combination chemotherapy plus radiation therapy is mo...
What is the current status of trial NCT00002611?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,031 participants. The study started on 1995-07. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00002611?
The interventions under investigation include: cyclophosphamide (DRUG), etoposide (DRUG), filgrastim (BIOLOGICAL), doxorubicin hydrochloride (DRUG), dactinomycin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00002611?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.